A b s t r a c t
In some patients, the presence of monoclonal IgM proteins can cause substantial false elevation in nephelometric assays. A 59-year-old woman with previously unrecognized
Positive interference of nephelometric assays in the presence of monoclonal IgM proteins has been previously described. [1] [2] [3] Potentially affected analytes include quantitative IgG and IgA immunoglobulins. 1,2 Interference seems to occur in only a minor fraction of patient samples containing IgM monoclonal protein. 1, 2 While incompletely understood, proposed mechanisms include precipitation of sample monoclonal proteins in reaction solutions, formation of antibody-antibody complexes with assay components, and nonspecific interactions between IgM and latex particles. [1] [2] [3] [4] Herein we report that the addition of a reducing agent in a chaotropic salt solution resulted in the reduction of artifactual elevation of nephelometric-assayed IgG and IgA concentrations in a patient with a high concentration of IgM monoclonal protein.
A 59-year-old woman had a history of generalized pain, fatigue, and bleeding. She was found to have increased total serum and urine protein concentrations, anemia, and thrombocytopenia. A peripheral blood smear and bone marrow biopsy revealed a monotypic κ-restricted B-lymphoid population immunophenotypically consistent with Waldenström macroglobulinemia. Serum protein electrophoresis was performed on a Sebia (Norcross, GA) CAPILLARYS platform and clearly indicated M-protein present in the γ region at 4.2 g/dL. Although type II mixed cryoglobulinemia (monoclonal IgM-IgG polyclonal) was noted, extremely high serum viscosity of 5.7 cP (reference interval, 1.1-1.5 cP) was observed after extensive incubation at 37°C. Immunofixation electrophoresis (IFE) performed on a Sebia HYDRASYS instrument repeatedly showed protein aggregate in the application wells in all lanes upon Upon completion of this activity you will be able to:
• describe proposed mechanisms for nephelometric interference observed in a subset of patients with IgM monoclonal gammopathy.
• outline a method for alleviation of IgM nephelometric interference using a reducing agent.
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staining. Nephelometric analysis at 37°C on a Siemens (Munich, Germany) BNII instrument unexpectedly revealed substantially elevated concentrations of IgG, IgA, and IgM.
Materials and Methods
To resolve observed cross-linked monoclonal protein by IFE, 20 μL of a 10% solution of greater than 99% pure β-mercaptoethanol (BME; Arcos Organics, Geel, Belgium) was added to 180 μL of Sebia IFE Fluidil chaotropic salt solution (Sebia). 5 This reducing fluid solution (100 μL) was added to a patient serum sample (300 μL), and IFE was performed. This sample pretreatment completely resolved a strong and distinct IgM κ monoclonal protein band. Fluidil solution alone was not sufficient to resolve higher order complexes by IFE.
To determine whether the addition of reducing agent could alleviate apparent nephelometric interference, comparative quantitative immunoglobulin analysis was performed on untreated specimens and specimens treated with reducing solution. Reducing fluid solution was prepared as outlined above, and 100 μL was added to 300 μL of patient serum sample. The concentration of BME present was the same concentration that effectively resolved immunoglobulin aggregates by IFE. The pretreated specimens were then immediately diluted 10-fold with Siemens nephelometer N-diluent fluid, and quantitative immunoglobulin analysis was performed. In addition, unrelated control patient samples containing IgG, IgM, and IgA monoclonal protein were identified and treated with reducing solution as described above. All untreated specimens in this study were introduced directly into the nephelometer for automated dilution in N-diluent.
Finally, an additional patient control sample containing no monoclonal protein was also treated with reducing solution. However, in contrast with previous specimens and control samples, this specimen was diluted 2-fold with N-diluent before introduction into the nephelometer to maintain immunoglobulin concentrations above the minimal analytic range of the assays.
Results
The treated patient sample exhibited a greater than 50% drop in measured IgG and IgA concentrations in the presence of reducing agent, while the measured IgM concentration exhibited no significant decrease in the presence of reducing agent ❚Table 1❚. Three control specimens with significant IgG, IgA, or IgM component exhibited no significant change in measured immunoglobulins on treatment. Minor differences were observed between treated and untreated specimens from the control patient without monoclonal protein elevation. However, concentration measurements in this treated sample were obtained by back calculation from diluted antibody concentrations near the lower limit of the analytic measurement range of these assays, which may have affected measurement accuracy. 
